Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Scorpio2on Sep 29, 2018 10:36am
142 Views
Post# 28714443

RE:RE:made2last

RE:RE:made2lastIt all depends upon how many shares are made available for "securities lending" in the marketplace.

The best thing we can do as shareholders is to make sure that if your TLT shares are held in a margin account, that you do not go into a negative cash position because that allows your broker to place your shares on loan (without your consent or knowledge) to whomever wants to borrow them (rent them) for a fee. As an FYI, if your shares are loaned out, you will never know cause they will appear as an asset in your account but they have been loaned out to a shorter. Technically it becomes an obligation of your broker to make your account whole. For example, if you wanted to sell your TLT shares that have been loaned out,  your broker would simply take the shares from somewhere else in their system to satisfy your sale. Don't kid yourself, securities lending is a big business for institution custodians/brokers and represents 1/3 of their fee revenue split out as 1/3 direct custodial/trading fees, 1/3 securities lending fees and 1/3 f/x fees on the spreads.  

Another way to prevent share from being loaned out of a margin account regardless of the cash position, is to just put them up for on-going sale in the margin account at some very high price i.e. $20.  

I don't believe that shares can be loaned out of any registered accounts like RRSP, TFSA RPP etc. so no issue there in terms of your shares being loaned out to shorters.

 
Bullboard Posts